Gene-Signature-May-Predict-Response-To-Cancer-Chemotherapy
An eight gene ‘signature’ can predict length of relapse-free survival after chemotherapy, according to new research from Taiwan.
An eight gene ‘signature’ can predict length of relapse-free survival after chemotherapy, according to new research from Taiwan.
In a study published in the journal BMC Medicine, Researchers from Academia Sinica and the National Taiwan University College of Medicine first identified genes that were involved in cellular invasion, a property of many cancer cells, using the National Cancer Institute’s 60 human cancer cell line panel (NCI-60).
By comparing the pattern of activation of each of these genes in different cell lines with how these cell lines responded to 99 different anti-cancer drugs, the researchers narrowed down the list of genes to just those which could potentially influence the outcome of chemotherapy.
The eight-gene signature featured the cancer hallmark gene, epidermal growth factor receptor (EGFR), and genes involved in cell adhesion, migration, invasion, tumor growth, and progression.
In clinical studies, they found that patients with lung and breast cancer whose gene signature put them in the low-risk group had a longer relapse free survival than the high-risk group.
The Latest on: Chemotherapy
via Google News
The Latest on: Chemotherapy
- Minnesota teacher with cancer continues virtual classes, even during chemotherapyon January 26, 2021 at 3:52 pm
Kelly Klein is that teacher everyone remembers — even during a year she'd rather forget. Klein isn't only tackling virtual learning. She's doing it while battling a recurrence of ovarian cancer. She's ...
- Preventing Chemotherapy From Damaging the Hearton January 26, 2021 at 12:44 pm
Researchers have discovered that the chemotherapy drug doxorubicin is able to enter heart cells by hitchhiking on a specific type of protein that functions as a transporter to move drugs from the ...
- Drug intervention may prevent heart damage caused by chemotherapyon January 26, 2021 at 9:33 am
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
- Global Chemotherapy Infusion Pumps Market 2020 SWOT Study, PESTEL Analysis and Forecast by 2025 - Impact of Corona Virus Outbreakon January 25, 2021 at 4:00 pm
Jan (CDN Newswire via Comtex) -- The latest informative study entitled Global Chemotherapy Infusion Pumps Market 2020 by Manufacturers, Type ...
- Finding a way to stop chemotherapy from damaging the hearton January 25, 2021 at 2:18 pm
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
- UToledo awarded Department of Defense funding to advance promising new chemotherapyon January 24, 2021 at 9:04 pm
The project relies on a unique cell death pathway to overcome the multidrug resistance that often characterizes triple negative breast cancer.
- Bills fan celebrates end of chemotherapy in style with table and all (Video)on January 22, 2021 at 8:49 pm
This Buffalo Bills fan celebrates life and the end of chemotherapy the way only a true Bills fan would, with a table and all. The new year is off to a ...
- Dustin Diamond begins chemotherapy after cancer diagnosison January 22, 2021 at 8:13 am
Dustin Diamond, who played Samuel "Screech" Powers on "Saved by the Bell," completed a first round of chemotherapy for stage 4 lung cancer.
- Dustin Diamond Begins Chemotherapy for Stage 4 Lung Canceron January 21, 2021 at 11:10 pm
Dustin Diamond, who portrayed Screech on Saved by the Bell, has completed his first round of chemotherapy after being diagnosed with stage 4 lung cancer.
- Dustin Diamond undergoing chemotherapy treatments for canceron January 21, 2021 at 12:13 pm
Original “Saved by the Bell” star Dustin Diamond has begun undergoing chemotherapy treatments after being diagnosed with cancer, according to his representative ...
via Bing News
